Trial Profile
Multicenter patient named program of Azacitidine for use in older patients with acute myeloid leukemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 28 Nov 2015 New trial record